Clinical Trial Update: Infliximab to Treat Non-Infectious Scleritis [Phase 1]

View source ↗

Summary

This clinical trial update reports that an early-phase study evaluating infliximab for non-infectious scleritis has completed Phase 1. The trial is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Scleritis | Phase 1 | Status: COMPLETED